Dr. Oz, Host Of The Dr. Oz Show, and Harry Zhabilov Of Immunotech Laboratories Discuss Immunotherapy Treatments For Cancer, HIV/AIDS

HUNTINGTON BEACH, Calif., Feb. 6, 2013 /PRNewswire/ -- Recently www.UndiscoveredCompanies.com was able to ask Dr. Mehmet Oz, host of the Dr. Oz show and Harry Zhabilov, President of Immunotech Laboratories (PINKSHEETS:IMMB) about Immunotherapy Treatments and how they are used to treat patients suffering with Cancer, and HIV/AIDS Virus.

Dr. Oz demonstrates an amazing wealth of knowledge in Immunotherapy.  The Doctor is not only charismatic, but also articulates his incredible knowledge about the treatment thoroughly.  Dr. Otis Brawley from the American Cancer Society also added some unique advancement comments about Immunotherapy Treatments.

Please view the video featuring Harry Zhabilov, Dr. Oz, and Dr. Otis Brawley at the following YouTube link. http://youtu.be/D0SvkO_jMK4

Review video testimonials of now symptom free Cancer and HIV patients treated with Immunotech's IPF Technology at http://www.lifechoicemx.com

About Immunotech Laboratories
Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases suck as HIV, Cancer, Hepatitis and Aids. Immunotech is committed to creating drugs for the better health of mankind.

About Undiscovered Companies
Undiscovered Companies is a video news provider of public and private companies looking for new marketing ideas and product exposure.  Subscribe at http://undiscoveredcompanies.com for free.

Safe Harbor Statement: This release may include the use of forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Disclosure: UndiscoveredCompanies.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit our website, for complete risks and disclosures.

Contact
Immunotech Laboratories
IR@immunotechlab.com

Contact
Undiscovered Companies
info@undiscoveredcompanies.com

CSNNewswire.com
info@csnnewswire.com

SOURCE Immunotech Laboratories, Inc.




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.